<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00196157</url>
  </required_header>
  <id_info>
    <org_study_id>GE IDE No. C00604</org_study_id>
    <nct_id>NCT00196157</nct_id>
  </id_info>
  <brief_title>Line Versus Spot Ablation in Persistent Atrial Fibrillation</brief_title>
  <official_title>Linear Anatomically Versus Focal Electrophysiologically Guided Substrate Ablation in Patients With Persistent Atrial Fibrillation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Deutsches Herzzentrum Muenchen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Deutsches Herzzentrum Muenchen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this randomized study dealing with the ablative treatment of persistent atrial
      fibrillation, two ablation strategies are compared: a more anatomically guided linear
      ablation scheme versus an electrophysiological guided focal ablation strategy aiming at the
      electrical isolating of the pulmonary veins and ablating areas of fragmented intracardiac
      electrograms thought to maintain atrial fibrillation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This randomized study deals with two different ablative treatment strategies for persistent
      atrial fibrillation: a more anatomically guided linear ablation scheme with encircling of the
      ipsilateral pulmonary veins (PV), a left atrial roof line and an anterior line bridging the
      anterior mitral anulus to the ostium of the left superior PV versus an electrophysiological
      guided focal ablation strategy aiming at isolating, electrically, the PV and ablating areas
      of fragmented intracardiac electrograms thought to maintain atrial fibrillation.

      Both ablation approaches contain isolation of the most common source of triggering foci,
      i.e., the pulmonary veins and additional modification of the substrate maintaining atrial
      fibrillation.

      The study endpoint is a combined efficacy/safety analysis. Extensive follow-up with
      three-monthly 7 days holter ECG is provided.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2004</start_date>
  <completion_date type="Anticipated">November 2008</completion_date>
  <primary_completion_date type="Anticipated">May 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sinus rhythm in follow-up</measure>
    <time_frame>Sinus rhythm in follow-up</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">116</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>linear lesions to ablate persistent atrial fibrillation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>focal electrophysiologically guided ablations to treat persistent atrial fibrillation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>linear anatomically oriented ablations</intervention_name>
    <description>linear lesions to ablate persistent atrial fibrillation</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>focal electrophysiological oriented ablations</intervention_name>
    <description>focal electrophysiologically guided ablations to treat persistent atrial fibrillation</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age between 18 and 80 years

          -  symptomatic persistent (&gt; 7 days lasting) atrial fibrillation

          -  at least one unsuccessful cardioversion or atrial fibrillation relapse in the first 3
             months after cardioversion despite antiarrhythmic drug therapy

          -  oral anticoagulation (&gt; 4 weeks prior to ablation)

        Exclusion Criteria:

          -  moderate to severe valvular heart disease

          -  congenital heart disease

          -  LV-EF &lt; 35%

          -  reversible cause for atrial fibrillation (e.g., hyperthyreosis)

          -  prior left atrial ablation or Maze operation

          -  left atrial thrombus
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claus Schmitt, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Deutsches Herzzentrum Muenchen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Heidi Estner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Deutsches Herzzentrum Muenchen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Heidi Estner, MD</last_name>
    <phone>0049 89 1218 2020</phone>
    <email>estner@dhm.mhn.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Deutsches Herzzentrum Muenchen</name>
      <address>
        <city>Munich</city>
        <zip>80636</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heidi Estner, MD</last_name>
      <phone>0049 89 1218 2020</phone>
      <email>estner@dhm.mhn.de</email>
    </contact>
    <investigator>
      <last_name>Heidi Estner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2005</study_first_submitted>
  <study_first_submitted_qc>September 19, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2005</study_first_posted>
  <last_update_submitted>May 28, 2009</last_update_submitted>
  <last_update_submitted_qc>May 28, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 29, 2009</last_update_posted>
  <responsible_party>
    <name_title>Prof. A. Sch√∂mig</name_title>
    <organization>Deutsches Herzzentrum Munich</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

